When they start disusing how you can't short someone please start debating with the DTCC loophole that they are actually using to do so. Also cite the article from yesterday where the US supreme court ruled in favor of law suits to be brought upon these individuals on a state level. The article specificity states their exact tactics of the type of message board manipulation that they deny their part of. Explain these points so that they can no longer deceive new shareholders into believe their lies spread from their short and distort fraud campaign.
We'll never know unless they tell us. Theyre using a
When they start disusing how you can't short someone please start debating with the DTCC loophole that they are actually using to do so. Also cite the article from yesterday where the US supreme court ruled in favor of law suits to be brought upon these individuals on a state level. The article specificity states their exact tactics of the type of message board manipulation that they deny their part of. Explain these points so that they can no longer deceive new shareholders into believe their lies spread from their short and distort fraud campaign.
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Arch Painting Champions Community Support at Major Event
Arch Painting's Commitment to Community Support Arch Painting, a prominent entity in paint contracting services, is taking significant steps to support community initiatives. Recently, the company made headlines by becoming a Gold Sponsor of the Mobility Awareness Resource Community (M.A.R.C.) Network during a high-profile football event. The sponsorship highlights Arch...
Continue Reading
Radioligand Therapy Market Growth Forecast to $10.9 Billion
Radioligand Therapy Market Growth and Future Outlook The global Radioligand Therapy (RLT) market is witnessing promising growth, with expectations to reach a valuation of USD 10.91 billion by the early 2030s, exhibiting a compound annual growth rate (CAGR) of 13.2% from 2025 onward. This significant progression can be attributed to the increasing number of approvals and...
Continue Reading
Boston Scientific Achieves Remarkable Growth in 2024 Earnings
Introduction to Boston Scientific's 2024 Financial Triumph Boston Scientific Corporation (NYSE: BSX) has announced impressive results for the fourth quarter and the entire year of 2024. The figures indicate robust growth in net sales and earnings, underscoring the company's strong position in the medical technology sector. During the fourth quarter, net sales reached a...
Continue Reading
Top Tech Stocks to Watch: Momentum Indicators to Note
Key Technology Stocks Exhibiting Momentum The information technology sector continues to capture the attention of investors, particularly those who prioritize momentum as a vital part of their trading strategies. In the rapidly evolving landscape of tech stocks, three companies have recently emerged as noteworthy players due to significant momentum indicators that may...
Continue Reading
Autoliv Exceeds Expectations as Key Stocks Surge on Friday
Autoliv Reports Strong Third-Quarter Results On a recently mixed trading day for U.S. stocks, significant gains were noted with the Nasdaq Composite surging approximately 100 points. Among the noteworthy performers, shares of Autoliv, Inc. exhibited an impressive increase following the company’s announcement concerning its third-quarter financial performance. Key...
Continue Reading